Affiliation:
1. Rostov state medical university
Abstract
Hypogonadism is a condition associated with a decrease in the functional activity of the testicles, accompanied by a decrease in the level of androgens and (or) a violation of the process of spermatogenesis. It is known that androgens and their main representative, testosterone, are of fundamental importance for the development and maintenance of the reproductive and sexual functions of the male reproductive system. At the same time, low testosterone levels are associated with both reproductive and metabolic disorders, including phosphorus-calcium, fat, carbohydrate, and protein metabolism. In addition, to date, data have been accumulated on the correlation of hypogonadism with cardiovascular diseases, which once again emphasizes the problem of testosterone deficiency, especially for patients of the middle and older age groups. However, carrying out testosterone replacement therapy always requires a strict and competent choice of a «target audience» among patients from a specialist. Today, on the pharmaceutical market, there is a wide arsenal of testosterone-containing drugs in various forms for use, which have an unequal «efficacy-safety» profile. In this review, we have analyzed modern approaches to the diagnosis and treatment of hypogonadism, the selection of a target group of patients to obtain the most effective and safe treatment outcome and described testosterone preparations and their dosage forms with potential advantages and disadvantages. Thus, the information presented in the article is aimed at optimizing the management of men with hypogonadism.
Publisher
Endocrinology Research Centre
Subject
Public Health, Environmental and Occupational Health,Nutrition and Dietetics,Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine
Reference45 articles.
1. Dedov II, Melnichenko GA, Rozhivanov RV, et al. Clinical guide diagnisis and treatment gipogonadism (geficit of testosteron). The project. Problems of Endocrinology. 2015;61(5):60-71. (In Russ). doi: https://doi.org/10.14341/probl20156560-71
2. Demidova TYu, Skuridina DV. Testosterone transdermal gels for endocrine disorders from the viewpoint of evidence-based medicine. Russkij medicinskij zhurnal. Medicinskoe obozrenie. 2019;3(10-2);96-100. (In Russ.).
3. Tischovskii SV, Nikonova LV. Male hypogonadism: features of diagnosis and treatment. Lechebnoe delo: nauchnopracticheskii gurnal. 2021;2(77):41-48. (In Russ.).
4. Dohle (Chair) GR, Arver S, Bettocchi C, Jones TH, et al. EAU Guidelines on Male Hypogonadism. European Association of Urology; 2016. 26 p.
5. Ametov AS, Pashova EYu. Testosterone therapy evolution. New preparations — new benefits. Endocrinologia: Novosti. Mneniya. Obuchenie. 2017;2(19):55-65. (In Russ.).
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献